guest ::
| Home > Publications database > Dietary fatty acids and endometrial cancer risk within the European Prospective Investigation into Cancer and Nutrition. > print |
| Home > Publications database > Dietary fatty acids and endometrial cancer risk within the European Prospective Investigation into Cancer and Nutrition. > print |
| 001 | 271228 | ||
| 005 | 20240229154923.0 | ||
| 024 | 7 | _ | |a 10.1186/s12885-023-10611-0 |2 doi |
| 024 | 7 | _ | |a pmid:36797668 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC9936701 |2 pmc |
| 024 | 7 | _ | |a altmetric:142653617 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2023-00365 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Yammine, S. G. |b 0 |
| 245 | _ | _ | |a Dietary fatty acids and endometrial cancer risk within the European Prospective Investigation into Cancer and Nutrition. |
| 260 | _ | _ | |a Heidelberg |c 2023 |b Springer |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1676976414_21826 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Diet may impact important risk factors for endometrial cancer such as obesity and inflammation. However, evidence on the role of specific dietary factors is limited. We investigated associations between dietary fatty acids and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).This analysis includes 1,886 incident endometrial cancer cases and 297,432 non-cases. All participants were followed up for a mean of 8.8 years. Multivariable Cox proportional hazard models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) of endometrial cancer across quintiles of individual fatty acids estimated from various food sources quantified through food frequency questionnaires in the entire EPIC cohort. The false discovery rate (q-values) was computed to control for multiple comparisons.Consumption of n-6 γ-linolenic acid was inversely associated with endometrial cancer risk (HR comparing 5th with 1st quintileQ5-Q1=0.77, 95% CI = 0.64; 0.92, ptrend=0.01, q-value = 0.15). This association was mainly driven by γ-linolenic acid derived from plant sources (HRper unit increment=0.94, 95%CI= (0.90;0.98), p = 0.01) but not from animal sources (HRper unit increment= 1.00, 95%CI = (0.92; 1.07), p = 0.92). In addition, an inverse association was found between consumption of n-3 α-linolenic acid from vegetable sources and endometrial cancer risk (HRper unit increment= 0.93, 95%CI = (0.87; 0.99), p = 0.04). No significant association was found between any other fatty acids (individual or grouped) and endometrial cancer risk.Our results suggest that higher consumption of γ-linolenic acid and α-linoleic acid from plant sources may be associated with lower risk of endometrial cancer. |
| 536 | _ | _ | |a 313 - Krebsrisikofaktoren und Prävention (POF4-313) |0 G:(DE-HGF)POF4-313 |c POF4-313 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 650 | _ | 7 | |a Diet |2 Other |
| 650 | _ | 7 | |a Endometrial cancer |2 Other |
| 650 | _ | 7 | |a Epidemiology |2 Other |
| 650 | _ | 7 | |a Fatty acids |2 Other |
| 700 | 1 | _ | |a Huybrechts, I. |b 1 |
| 700 | 1 | _ | |a Biessy, C. |b 2 |
| 700 | 1 | _ | |a Dossus, L. |b 3 |
| 700 | 1 | _ | |a Panico, S. |b 4 |
| 700 | 1 | _ | |a Sánchez, M. J. |b 5 |
| 700 | 1 | _ | |a Benetou, V. |b 6 |
| 700 | 1 | _ | |a Turzanski-Fortner, R. |0 P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2 |b 7 |u dkfz |
| 700 | 1 | _ | |a Katzke, V. |0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4 |b 8 |u dkfz |
| 700 | 1 | _ | |a Idahl, A. |b 9 |
| 700 | 1 | _ | |a Skeie, G. |b 10 |
| 700 | 1 | _ | |a Olsen, K Standahl |b 11 |
| 700 | 1 | _ | |a Tjønneland, A. |b 12 |
| 700 | 1 | _ | |a Halkjaer, J. |b 13 |
| 700 | 1 | _ | |a Colorado-Yohar, S. |b 14 |
| 700 | 1 | _ | |a Heath, A. K. |b 15 |
| 700 | 1 | _ | |a Sonestedt, E. |b 16 |
| 700 | 1 | _ | |a Sartor, H. |b 17 |
| 700 | 1 | _ | |a Schulze, M. B. |b 18 |
| 700 | 1 | _ | |a Palli, D. |b 19 |
| 700 | 1 | _ | |a Crous-Bou, M. |b 20 |
| 700 | 1 | _ | |a Dorronsoro, A. |b 21 |
| 700 | 1 | _ | |a Overvad, K. |b 22 |
| 700 | 1 | _ | |a Gurrea, A Barricarte |b 23 |
| 700 | 1 | _ | |a Severi, G. |b 24 |
| 700 | 1 | _ | |a Vermeulen, R. C. H. |b 25 |
| 700 | 1 | _ | |a Sandanger, T. M. |b 26 |
| 700 | 1 | _ | |a Travis, R. C. |b 27 |
| 700 | 1 | _ | |a Key, T. |b 28 |
| 700 | 1 | _ | |a Amiano, P. |b 29 |
| 700 | 1 | _ | |a Van Guelpen, B. |b 30 |
| 700 | 1 | _ | |a Johansson, M. |b 31 |
| 700 | 1 | _ | |a Sund, M. |b 32 |
| 700 | 1 | _ | |a Tumino, R. |b 33 |
| 700 | 1 | _ | |a Wareham, N. |b 34 |
| 700 | 1 | _ | |a Sacerdote, C. |b 35 |
| 700 | 1 | _ | |a Krogh, V. |b 36 |
| 700 | 1 | _ | |a Brennan, P. |b 37 |
| 700 | 1 | _ | |a Riboli, E. |b 38 |
| 700 | 1 | _ | |a Weiderpass, E. |b 39 |
| 700 | 1 | _ | |a Gunter, M. J. |b 40 |
| 700 | 1 | _ | |a Chajès, V. |b 41 |
| 773 | _ | _ | |a 10.1186/s12885-023-10611-0 |g Vol. 23, no. 1, p. 159 |0 PERI:(DE-600)2041352-X |n 1 |p 159 |t BMC cancer |v 23 |y 2023 |x 1471-2407 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:271228 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-313 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Krebsrisikofaktoren und Prävention |x 0 |
| 914 | 1 | _ | |y 2023 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2022-11-19 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2022-11-19 |
| 915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2022-11-19 |
| 915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2022-11-19 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b BMC CANCER : 2022 |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2023-05-21T15:34:55Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2023-05-21T15:34:55Z |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Open peer review |d 2023-05-21T15:34:55Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-10-24 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2023-10-24 |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2023-10-24 |
| 920 | 1 | _ | |0 I:(DE-He78)C020-20160331 |k C020 |l C020 Epidemiologie von Krebs |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)C020-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|